Historical shareholding details of
Public
holdings in GlaxoSmithKline Pharmaceuticals Ltd. (GLAXO)
Quarterly changes of
Public
shareholding in GlaxoSmithKline Pharmaceuticals Ltd.
over the previous
quarters
|
Quarter
|
Name |
Total no. shares held |
Percent Holding |
Pledged
|
Locked
|
|
shares
|
%
|
shares
|
%
|
|
Sep 2025
|
Total
|
21,092,194
|
12.00%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2025
|
Total
|
21,024,395
|
12.41%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2025
|
Total
|
21,499,890
|
12.69%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2024
|
Total
|
22,347,951
|
13.21%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2024
|
Total
|
22,533,687
|
13.30%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2024
|
Total
|
22,836,365
|
13.48%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2024
|
Total
|
23,079,460
|
13.62%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2023
|
Total
|
22,746,638
|
13.42%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2023
|
Total
|
21,149,815
|
12.48%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2023
|
Total
|
20,912,860
|
12.35%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2023
|
Total
|
21,049,923
|
12.43%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2022
|
Total
|
21,060,839
|
12.43%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2022
|
Total
|
20,822,462
|
12.29%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2022
|
Total
|
20,649,609
|
12.19%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2022
|
Total
|
20,478,201
|
12.09%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2021
|
Total
|
20,713,656
|
12.22%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2021
|
Total
|
21,099,165
|
12.45%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2021
|
Total
|
21,107,834
|
12.46%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2021
|
Total
|
21,281,957
|
12.56%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2020
|
Total
|
21,498,383
|
12.69%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2020
|
Total
|
21,614,348
|
12.76%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2020
|
Total
|
21,441,589
|
12.65%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2020
|
Total
|
22,584,464
|
13.32%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2019
|
Total
|
22,824,946
|
13.47%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2019
|
Total
|
22,860,003
|
13.49%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2019
|
Total
|
21,217,215
|
12.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2019
|
Total
|
21,130,718
|
12.47%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2018
|
Total
|
21,205,748
|
12.52%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2018
|
Total
|
21,382,658
|
12.63%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2018
|
Total
|
10,530,428
|
12.43%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2018
|
Total
|
10,643,005
|
12.56%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2017
|
Total
|
10,709,494
|
12.64%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2017
|
Total
|
10,736,449
|
12.68%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2017
|
Total
|
10,857,222
|
12.82%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2017
|
Total
|
10,939,503
|
12.91%
|
0
|
0.00%
|
0
|
0.00%
|
View all shareholdings details of GlaxoSmithKline Pharmaceuticals Ltd.